Venture Capital/Space, defense, robotics, semiconductors
Speciale Invest logo

Speciale Invest

Pre-seed fund research profile

Speciale Invest is an early-stage deep-tech specialist founded by Vishesh Rajaram and Arjun Rao. It backs science- and engineering-led companies from pre-seed through seed, with an emphasis on space, energy, advanced manufacturing, AI, robotics, semiconductors and life sciences.

At a glance

Founded
2017
Footprint
Chennai
Stage
Pre-seed/seed (deeptech-only)

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

Speciale Invest uses a pre-seed/seed (deeptech-only) approach across Space, defense, robotics, semiconductors.

Current evidence

Speciale’s 2025 investment and portfolio publications identify follow-on and new positions including InspeCity, Protecto, Morphing Machines, Unmannd, Newtrace, Ultraviolette and Anubal Fusion.

Strategy

Pre-seed/seed (deeptech-only)

Sector focus

Space, defense, robotics, semiconductors

AIF structure context

Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.

Current signal

Speciale’s 2025 investment and portfolio publications identify follow-on and new positions including InspeCity, Protecto, Morphing Machines, Unmannd, Newtrace, Ultraviolette and Anubal Fusion.

Investor questions

Speciale Invest research questions

What is Speciale Invest's investment strategy?

Speciale Invest is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Pre-seed/seed (deeptech-only), with a sector focus of Space, defense, robotics, semiconductors. The profile should be read with the linked source trail and Typical route: Category I AIF context.

What portfolio evidence is available for Speciale Invest?

The profile displays only company or asset names attributable to Speciale Invest in the reviewed public sources: Agnikul, ePlane, QNu Labs, Ultraviolette, Newtrace, Protecto, InspeCity, Morphing Machines, Unmannd. It does not represent a complete current portfolio unless the manager has published one.

What is known about Speciale Invest's performance or track record?

Fund III closed at ₹600 crore in 2025, above its ₹500 crore target, with reported plans for 18–20 investments and 50%+ follow-on capacity. The portfolio includes Agnikul Cosmos, GalaxEye, ePlane, Ultraviolette, CynLr and QNu Labs; audited fund returns are not disclosed. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are Speciale Invest's fund size, fees and minimum investment?

Public fund size: Fund III closed at ₹600 crore against a ₹500 crore target in August 2025.. Public terms or access information: Pre-seed and seed deep-tech investing; the GP describes a typical sweet spot around $750K–$1M and reserves 60% of corpus for follow-ons. Fund III reporting describes ₹7–10 crore initial cheques with flexibility to go higher.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on Speciale Invest's investment team?

The current source record names Vishesh Rajaram, Arjun Rao. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with Speciale Invest?

Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Follow-on capacity for deeptech capital intensity.

What is the latest public update on Speciale Invest?

2025: Speciale’s 2025 investment and portfolio publications identify follow-on and new positions including InspeCity, Protecto, Morphing Machines, Unmannd, Newtrace, Ultraviolette and Anubal Fusion.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →